--- title: "U.S. stock night trading opens with fluctuations: Lam Research rises 8.38% in night trading; Microsoft rises 7.95% in night trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/294278182.md" description: "Lam Research rose 8.38% in after-hours trading; Microsoft rose 7.95% in after-hours trading; Steakholder Foods rose 24.35% in after-hours trading; Corcept Medical rose 20.02% in after-hours trading; Globavend rose 19.78% in after-hours trading" datetime: "2026-07-30T00:22:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294278182.md) - [en](https://longbridge.com/en/news/294278182.md) - [zh-HK](https://longbridge.com/zh-HK/news/294278182.md) --- # U.S. stock night trading opens with fluctuations: Lam Research rises 8.38% in night trading; Microsoft rises 7.95% in night trading **U.S. Stock Night Trading Opening Movements** Lam Research rose 8.38% in night trading. Based on recent key news: 1. On July 29, Lam Research announced a strong first-quarter adjusted earnings per share guidance, expecting earnings of $2.15 per share, higher than analysts' expectations of $1.83. This optimistic financial guidance drove the stock price up 6% in after-hours trading. Source: Benzinga 2. On July 29, Lam Research released its fourth-quarter financial report, with revenue reaching $6.72 billion, exceeding market expectations of $6.67 billion. The strong financial performance further boosted investor confidence. Source: SEC announcement 3. On July 28, HSBC raised Lam Research's target price due to optimism about the strong performance of the wafer fabrication equipment market. Analysts believe market demand exceeded expectations, driving the stock price up. Source: Zhitong Finance Industry Demand Strong, Market Confidence Boosted Microsoft rose 7.95% in night trading. Based on recent key news: 1. On July 30, Microsoft announced its financial report, with quarterly cloud business revenue growth exceeding Wall Street expectations, Azure cloud computing revenue grew 43% year-over-year, higher than the expected 39.98%. This growth alleviated market concerns about surging data center spending, and the stock price rose about 4% in after-hours trading. Source: Jinshi Data 2. On July 30, Microsoft’s last quarter earnings surpassed market expectations, with strong cloud business performance, intelligent cloud business revenue growing 32%, and Azure's annual sales exceeding $10 billion for the first time, with the stock price rising over 7% in extended trading hours. Source: Now News Channel 3. On July 30, Microsoft’s Chief Financial Officer stated that the growth in cloud business revenue benefited from the early delivery of new computing power, with the new computing capacity quickly monetized, leading to a stock price increase of about 3% in after-hours trading. Source: Jinshi Data Tech Stocks Under Pressure, AI Investment Returns Under Focus. **Top Gainers in U.S. Night Trading** Steakholder Foods rose 24.35% in night trading. Based on recent key news: 1. On July 28, industry insiders revealed that Steakholder Foods' commercialization of alternative proteins and 3D-printed cultured meat has entered a critical testing phase. This news drove positive market expectations for the company, resulting in a 24.35% increase in stock price. The demand for alternative protein is growing, but risks need to be monitored. Corcept Therapeutics rose 20.02% in night trading. Based on recent key news: 1. On July 29, Corcept Therapeutics reported second-quarter revenue of $256.147 million, a year-over-year increase of 32%. The strong growth in the fields of endocrinology and oncology drove this result. Source: Reuters 2. On July 29, Corcept Therapeutics raised its 2026 revenue guidance to $1.1 billion to $1.2 billion, primarily due to the rapid market acceptance of Lifyorli and extensive payer coverage Source: Business Wire On July 29, Corcept Therapeutics management stated that the second quarter was a turning point, with Lifyorli sales and ongoing momentum in endocrinology being the main drivers. Source: Earnings Call Transcript The pharmaceutical industry has recently performed strongly, with significant capital inflows. Globavend rose 19.78% in after-hours trading. Based on recent key news: 1. On July 29, Globavend director Kai Man Fung increased his holdings by purchasing 4,634 shares of common stock at a price of $0.91 per share. This increase raised his total holdings of common stock to 61,858 shares. This news boosted market confidence and drove the stock price up. 2. There have been no other significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [LRCX.US](https://longbridge.com/en/quote/LRCX.US.md) - [MSFT.US](https://longbridge.com/en/quote/MSFT.US.md) - [STKH.US](https://longbridge.com/en/quote/STKH.US.md) - [CORT.US](https://longbridge.com/en/quote/CORT.US.md) - [GVH.US](https://longbridge.com/en/quote/GVH.US.md) ## Related News & Research - [Lam Research (NASDAQ:LRCX) Releases Earnings Results, Beats Expectations By $0.13 EPS](https://longbridge.com/en/news/294256400.md) - [Ross Gerber Says MSFT Is 'Crushing It,' Jim Cramer Calls Quarter a 'Tour De Force' After Earnings Beat](https://longbridge.com/en/news/294339260.md) - [LRCX: Record revenue and margin growth driven by AI demand, with strong outlook for next quarter](https://longbridge.com/en/news/294254072.md) - [Prosperity Consulting Group LLC Sells 3,332 Shares of Microsoft Corporation $MSFT](https://longbridge.com/en/news/294600743.md) - [Microsoft Expects FY2027 Capex To Grow Year-Over-Year](https://longbridge.com/en/news/294269889.md)